+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Over The Counter Drugs Market by Drug Type (Cold, Cough, & Allergy Medications, Dermatology & Skin Care, Digestive Health), Product Form (Capsules, Liquids/Syrups, Powders), Distribution Channel, Age Group, End-user - Global Forecast 2025-2030- Product Image
Over The Counter Drugs Market by Drug Type (Cold, Cough, & Allergy Medications, Dermatology & Skin Care, Digestive Health), Product Form (Capsules, Liquids/Syrups, Powders), Distribution Channel, Age Group, End-user - Global Forecast 2025-2030- Product Image
Sale

Over The Counter Drugs Market by Drug Type (Cold, Cough, & Allergy Medications, Dermatology & Skin Care, Digestive Health), Product Form (Capsules, Liquids/Syrups, Powders), Distribution Channel, Age Group, End-user - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4807786
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The over-the-counter (OTC) drugs market is rapidly transforming as self-care trends and digital advancements reshape purchasing and consumption patterns. Senior leaders must navigate evolving consumer behaviors and regulatory frameworks to sustain growth in this dynamic sector.

Market Snapshot: Over the Counter Drugs Market Growth & Outlook

The global over-the-counter drugs market continues to expand steadily, with growth driven by rising consumer health awareness, increased accessibility, and the integration of digital and offline sales channels. This sector attracts investment across multiple regions, fueled by regulatory updates and the convergence of self-care with technological capabilities. The OTC category encompasses a broad array of medication types and delivery forms, with market adoption accelerating amid a more proactive global health environment.

Scope & Segmentation

This report delivers actionable intelligence across a comprehensive range of market dimensions and strategic priorities.

  • Drug Types: Cold, Cough & Allergy Medications, Dermatology & Skin Care, Digestive Health, Eye & Ear Care, Pain Relief Medications, and Vitamins & Supplements
  • Product Forms: Capsules, Liquids or Syrups, Powders, Sprays, Suppositories, Tablets or Pills, Topical Creams, Ointments, and Gels
  • Distribution Channels: Offline (Pharmacies & Drug Stores, Supermarkets & Hypermarkets), Online
  • Age Groups: Adult, Geriatric, and Pediatric
  • End-Users: Healthcare Professionals, Individual Consumers, Institutional Users
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific
  • Key Countries: United States, Canada, Mexico, Brazil, Argentina, United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland, China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Leading Companies: Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, Bayer AG, Cipla Limited, Dr. Reddy’s Laboratories Inc., Genomma group, GSK plc, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Services, Inc., LNK International, Inc., Novartis AG, Perrigo Company plc, Pfizer Inc., Pierre Fabre S.A, PL Developments LLC, Procter & Gamble Manufacturing Company, Reckitt Benckiser LLC, Sanofi S.A., Sun Pharmaceutical Industries Limited, Taisho Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd, The Mentholatum Company, Inc., Tris Pharma, Inc., Viatris Inc., Wörwag Pharma GmbH & Co. KG, Zentiva Group, a.s.

Key Takeaways

  • Growth in the OTC drugs market is fueled by heightened consumer self-management of health conditions, particularly for minor ailments and preventative care solutions.
  • Digital transformation is driving both product discovery and purchasing, necessitating that manufacturers and retailers integrate robust e-commerce and digital engagement strategies alongside traditional channels.
  • Shifts in regulatory environments are shortening product development cycles and promoting innovation in both formulation and delivery, enabling faster introduction of differentiated offerings to address diverse consumer preferences.
  • Environmental, social, and governance practices, including sustainable packaging and ethical sourcing, now influence end-user and buyer decision-making, impacting brand trust and corporate reputation.
  • Emerging trends such as data-driven personalization and advanced analytics are shaping product targeting and customer engagement, with leading organizations leveraging these capabilities to strengthen loyalty and retention.
  • Strategic alliances and contract manufacturing partnerships enable scalable production and agile adjustment to market shifts, especially as demand fluctuates by therapeutic category and region.

Tariff Impact: Navigating Trade and Supply Chain Pressures

Recent United States tariff adjustments have increased cost pressures across sourcing and manufacturing, prompting market participants to adjust supplier relationships and explore nearshoring to strengthen resilience. These changes influence global pricing strategies and encourage investment in regional manufacturing hubs to buffer against trade policy volatility. Adaptability in procurement and production is now critical to ensuring availability and mitigating duty-related challenges throughout distribution networks.

Methodology & Data Sources

This report is based on an integrated research approach that combines direct executive interviews with an in-depth review of peer-reviewed publications, industry data, and regulatory landscape analysis. Quantitative insights are validated using triangulation and proprietary scoring frameworks, ensuring consistency and accuracy across all findings.

Over the Counter Drugs Market: Why This Report Matters

  • Provides senior decision-makers a multi-dimensional understanding of market drivers—including regulatory, technological, and behavioral trends—to inform strategic planning.
  • Highlights actionable opportunities for portfolio optimization, supply chain adaptation, and competitive positioning across multiple geographies and product categories.
  • Supports investment and operational decisions with clear, credible analysis focused on actionable opportunities in the OTC and self-care pharmacy market.

Conclusion

The over-the-counter drugs market is characterized by technological evolution, shifting regulations, and expanding consumer self-care. Strategic agility and informed decision-making will be crucial for navigating and leading in this complex environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing consumer preference for digital health platforms integrating virtual consultations with OTC medication purchases
5.2. Accelerated growth in plant-based and organic OTC supplements driven by wellness-focused millennial demographics
5.3. Rising adoption of personalized dosage packaging and subscription services for chronic OTC medication users
5.4. Impact of regulatory shifts on accessibility of pseudoephedrine-containing decongestants in online pharmacies
5.5. Surge in demand for immune support OTC products fortified with elderberry, vitamin C, and zinc during viral seasons
5.6. Expansion of private label OTC pain relievers competing on price and targeted pain management formulations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Over The Counter Drugs Market, by Drug Type
8.1. Introduction
8.2. Cold, Cough, & Allergy Medications
8.2.1. Antihistamines
8.2.2. Cough Suppressants
8.2.3. Decongestants
8.3. Dermatology & Skin Care
8.3.1. Acne Treatments
8.3.2. Antifungal Creams
8.3.3. Skin Protectants
8.4. Digestive Health
8.4.1. Antacids
8.4.2. Anti-diarrheal
8.4.3. Laxatives
8.5. Eye & Ear Care
8.6. Pain Relief Medications
8.7. Vitamins & Supplements
9. Over The Counter Drugs Market, by Product Form
9.1. Introduction
9.2. Capsules
9.3. Liquids/Syrups
9.4. Powders
9.5. Sprays
9.6. Suppositories
9.7. Tablets/Pills
9.8. Topical Creams/Ointments/Gels
10. Over The Counter Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.2.1. Pharmacies & Drug Stores
10.2.2. Supermarkets & Hypermarkets
10.3. Online
11. Over The Counter Drugs Market, by Age Group
11.1. Introduction
11.2. Adult
11.3. Geriatric
11.4. Pediatric
12. Over The Counter Drugs Market, by End-user
12.1. Introduction
12.2. Healthcare Professionals
12.3. Individual Consumers
12.4. Institutional Users
13. Americas Over The Counter Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Over The Counter Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Over The Counter Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Amneal Pharmaceuticals LLC
16.3.2. Aurobindo Pharma Limited
16.3.3. Bayer AG
16.3.4. Cipla Limited
16.3.5. Dr. Reddy’s Laboratories Inc.
16.3.6. Genomma group
16.3.7. GSK plc
16.3.8. Hisamitsu Pharmaceutical Co., Inc.
16.3.9. Johnson & Johnson Services, Inc.
16.3.10. LNK International, Inc.
16.3.11. Novartis AG
16.3.12. Perrigo Company plc
16.3.13. Pfizer Inc.
16.3.14. Pierre Fabre S.A
16.3.15. PL Developments LLC
16.3.16. Procter & Gamble Manufacturing Company
16.3.17. Reckitt Benckiser LLC
16.3.18. Sanofi S.A.
16.3.19. Sun Pharmaceutical Industries Limited
16.3.20. Taisho Pharmaceutical Co., Ltd.
16.3.21. Teva Pharmaceutical Industries Ltd
16.3.22. The Mentholatum Company, Inc.
16.3.23. Tris Pharma, Inc.
16.3.24. Viatris Inc.
16.3.25. Wörwag Pharma GmbH & Co. KG
16.3.26. Zentiva Group, a.s.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. OVER THE COUNTER DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. OVER THE COUNTER DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. OVER THE COUNTER DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. OVER THE COUNTER DRUGS MARKET: RESEARCHAI
FIGURE 26. OVER THE COUNTER DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. OVER THE COUNTER DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. OVER THE COUNTER DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OVER THE COUNTER DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH SUPPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH SUPPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DECONGESTANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DECONGESTANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ACNE TREATMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ACNE TREATMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTIFUNGAL CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTIFUNGAL CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SKIN PROTECTANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SKIN PROTECTANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTACIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTI-DIARRHEAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANTI-DIARRHEAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY LAXATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY EYE & EAR CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY EYE & EAR CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PAIN RELIEF MEDICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PAIN RELIEF MEDICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS & SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS & SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY LIQUIDS/SYRUPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY LIQUIDS/SYRUPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY POWDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SPRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SPRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY TABLETS/PILLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY TABLETS/PILLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY TOPICAL CREAMS/OINTMENTS/GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY TOPICAL CREAMS/OINTMENTS/GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PHARMACIES & DRUG STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PHARMACIES & DRUG STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HEALTHCARE PROFESSIONALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HEALTHCARE PROFESSIONALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY INDIVIDUAL CONSUMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY INDIVIDUAL CONSUMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY INSTITUTIONAL USERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY INSTITUTIONAL USERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 134. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 135. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 136. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 137. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 138. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 139. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 140. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 141. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 144. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 145. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 146. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 147. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 148. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 149. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 156. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 157. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 158. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 159. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 164. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 165. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 166. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 241. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 244. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 245. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 248. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 249. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 250. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 251. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 254. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 255. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 256. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 257. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 258. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 259. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 260. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 262. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 263. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 266. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 267. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 268. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 269. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 274. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 275. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 276. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 295. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 296. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 297. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 298. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 299. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 300. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 301. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 302. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 303. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 304. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 305. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 308. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 309. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 310. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 311. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 312. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 313. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 314. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 315. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 316. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY COLD, COUGH, & ALLERGY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 317. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2018-2024 (USD MILLION)
TABLE 318. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY & SKIN CARE, 2025-2030 (USD MILLION)
TABLE 319. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2024 (USD MILLION)
TABLE 320. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY DIGESTIVE HEALTH, 2025-2030 (USD MILLION)
TABLE 321. SPAIN OVER THE COUNTER DRUGS MARKE

Samples

Loading
LOADING...

Companies Mentioned

  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma Limited
  • Bayer AG
  • Cipla Limited
  • Dr. Reddy’s Laboratories Inc.
  • Genomma group
  • GSK plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson Services, Inc.
  • LNK International, Inc.
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Pierre Fabre S.A
  • PL Developments LLC
  • Procter & Gamble Manufacturing Company
  • Reckitt Benckiser LLC
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Taisho Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd
  • The Mentholatum Company, Inc.
  • Tris Pharma, Inc.
  • Viatris Inc.
  • Wörwag Pharma GmbH & Co. KG
  • Zentiva Group, a.s.

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 56.75 Billion
Forecasted Market Value ( USD ) by 2030 $ 86.58 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

United States Over-The-Counter Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

United States Over-The-Counter Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 100 Pages
  • United States
From
North America OTC Health Products Market Size, Share & Trends Analysis By Application (Digestive Health, Women's Health), Form (Liquid, Gummies), Product, Demography, Distribution Channel, and Segment Forecasts, 2025-2030 - Product Image

North America OTC Health Products Market Size, Share & Trends Analysis By Application (Digestive Health, Women's Health), Form (Liquid, Gummies), Product, Demography, Distribution Channel, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • North America
From
Over the Counter (OTC) Drugs - Global Strategic Business Report - Product Image

Over the Counter (OTC) Drugs - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Digestive & Intestinal Remedies Market Size, Share & Trends Analysis Report By Type (Digestive Medicines), By Age Group (Adult & Geriatric, Pediatric), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Digestive & Intestinal Remedies Market Size, Share & Trends Analysis Report By Type (Digestive Medicines), By Age Group (Adult & Geriatric, Pediatric), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 80 Pages
  • Global
From
Digestive Remedies Market: Analysis By Type, By Formulation, By Distribution Channel, By End User, By Region Size and Trends and Forecast up to 2029 - Product Image

Digestive Remedies Market: Analysis By Type, By Formulation, By Distribution Channel, By End User, By Region Size and Trends and Forecast up to 2029

  • Report
  • 168 Pages
  • Global
From

About the Over the Counter (OTC) Drugs Market

The Over the Counter (OTC) Drugs market is a segment of the pharmaceutical industry that includes drugs that can be purchased without a prescription. These drugs are typically used to treat minor ailments such as headaches, colds, and allergies. OTC drugs are generally considered safe and effective when used as directed. OTC drugs are regulated by the Food and Drug Administration (FDA) and must meet certain safety and efficacy standards. The FDA also requires that OTC drugs be labeled with clear instructions for use. Some of the major players in the OTC Drugs market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Bayer, and Novartis. These companies produce a wide range of OTC drugs, including pain relievers, cold and flu remedies, antacids, and allergy medications. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.